DB18646InvestigationalGene Therapies
Divesiran is a synthetic double-stranded siRNA oligonucleotide directed against TMPRSS6 mRNA and covalently linked to a ligand containing 3 N-acetylgalactosamine residues.
- Code names
- SLN-124
Resolves to
Compound
What you can answer from here — as of September 17, 2025
Which companies are running trials of Divesiran, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account